A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset-Reference-Cited by-同舟云学术

A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset

Published:2017-09 Issue:3 Volume:124 Page:403-410
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Jang Bum-Sup,Kim In Ah

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference45 articles.

1. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials;McGale;Lancet (London, England),2014

2. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials;Group EBCTC;Lancet,2011

3. A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation;Eschrich;Int J Radiat Oncol Biol Phys,2009

4. Validation of a radiosensitivity molecular signature in breast cancer;Torres-Roca;Cancer Res,2012

5. Validation of a radiosensitivity molecular signature in breast cancer;Eschrich;Clin Cancer Res,2012

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting radiotherapy efficacy and prognosis in tongue squamous cell carcinoma through an in-depth analysis of a radiosensitivity gene signature;Frontiers in Oncology;2024-08-26

2. Integrating Radiosensitivity Gene Signature Improves Glioma Outcome and Radiotherapy Response Prediction;Medicina;2022-09-22

3. Optimal management of recurrent and metastatic upper tract urothelial carcinoma: Implications of intensity modulated radiation therapy;Radiation Oncology;2022-03-09

4. Anti-PD-L1 Antibody Enhances T Cell Immune Responses and Reduces Resistance of Breast Cancer Cells to Radiotherapy;Oxidative Medicine and Cellular Longevity;2022-03-07

5. RadSigBench: a framework for benchmarking functional genomics signatures of cancer cell radiosensitivity;Briefings in Bioinformatics;2022-01-22